Protein Degradation and InhibitorsHER2/EGFR in Cancer ResearchChromatin Remodeling and Cancer
2026.2.9Biochemist
Abstract
Abstract is not available.
Citation format
. Potential of PROTACs in selective cancer therapy. Biochemist, 2026, 48(1): 65–66.